Advertisement First Application of Haselmeier's Axis-D Injection Pen in Launched - Pharmaceutical Business review

Advertisement

Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Whitepapers

First Application of Haselmeier’s Axis-D Injection Pen in Launched

Haselmeier has announced that the first application of its Axis-D pen platform has been launched.

Commissioned by its client Merck Serono, a division of Merck, Germany, the new injection device has been designed to allow self-injection by patients of a ready to use biopharmaceutical solution for injection.

Download to find out more.